# Shaun G. Goodman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shaun-g-goodman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,508 |
| Field | Acute Myocardial Infarction Research |
| h-index | 102 |
| i10-index | 385 |
| Last Known Institution | University of Toronto |
| OpenAlex ID | https://openalex.org/A5047187243 |
| ORCID iD | 0000-0001-8068-2440 |
| Works | 802 |

## Researcher papers

Showing 12 of 18.

- [Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome](https://scholariq.org/papers/alirocumab-and-cardiovascular-outcomes-after-acute-coronary-syndrome/)
- [Initial Invasive or Conservative Strategy for Stable Coronary Disease](https://scholariq.org/papers/initial-invasive-or-conservative-strategy-for-stable-coronary-disease/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)](https://scholariq.org/papers/prediction-of-risk-of-death-and-myocardial-infarction-in-the-six-months-after/)
- [A Validated Prediction Model for All Forms of Acute Coronary Syndrome](https://scholariq.org/papers/a-validated-prediction-model-for-all-forms-of-acute-coronary-syndrome/)
- [Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation](https://scholariq.org/papers/antithrombotic-therapy-after-acute-coronary-syndrome-or-pci-in-atrial/)
- [Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome](https://scholariq.org/papers/apixaban-with-antiplatelet-therapy-after-acute-coronary-syndrome/)
- [Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006](https://scholariq.org/papers/decline-in-rates-of-death-and-heart-failure-in-acute-coronary-syndromes-1999/)
- [Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization](https://scholariq.org/papers/prasugrel-versus-clopidogrel-for-acute-coronary-syndromes-without/)
- [Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease](https://scholariq.org/papers/evacetrapib-and-cardiovascular-outcomes-in-high-risk-vascular-disease/)
- [Intravenous Platelet Blockade with Cangrelor during PCI](https://scholariq.org/papers/intravenous-platelet-blockade-with-cangrelor-during-pci/)
- [Platelet Inhibition with Cangrelor in Patients Undergoing PCI](https://scholariq.org/papers/platelet-inhibition-with-cangrelor-in-patients-undergoing-pci/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [University of Toronto](https://scholariq.org/institutions/university-of-toronto/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.